Poulton Jeffrey V.
Alnylam Pharmaceuticals Inc · EVP
Poulton Jeffrey V. is listed in filings as EVP at Alnylam Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 6, 2026, including sale activity. Recent filings connect the profile to Alnylam Pharmaceuticals Inc (ALNY) and CervoMed Inc. (CRVO). The current snapshot covers public activity from Jun 14, 2024 to Mar 6, 2026. Reported amounts are shown as $264.9K to $99.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $265k818 shares | SellMar 4, 2026 | $323.84 | $292.16 | |
| $121k374 shares | SellMar 4, 2026 | $323.01 | $292.16 | |
| $99k309 shares | SellMar 4, 2026 | $321.82 | $292.16 | |
| $95k291 shares | SellMar 4, 2026 | $324.88 | $292.16 | |
| $74k230 shares | SellMar 4, 2026 | $320.81 | $292.16 | |
| $73k223 shares | SellMar 4, 2026 | $325.67 | $292.16 | |
| $36k114 shares | SellMar 4, 2026 | $319.03 | $292.16 | |
| $35k109 shares | SellMar 4, 2026 | $320.01 | $292.16 |